Author

Hakim Makhloufi

Observed name: H. Makhloufi

Institution: Transgene (France)

Observed institution: Transgene (France)

OpenAlex ID: A5057614342

Phase Ib/II trial of tipapkinogene sovacivec, a therapeutic human papillomavirus16-vaccine, in combination with avelumab in patients with advanced human papillomavirus16-positive cancers

2023 · Edith Borcoman, Ana Lalanne, et al. · European Journal of Cancer · 23

Safety and immunogenicity of TG4050: A personalized cancer vaccine in head and neck carcinoma.

2023 · Christian H.H. Ottensmeier, Jean-Pierre Delord, et al. · Journal of Clinical Oncology · 11

Randomized phase II trial evaluating the combination of TG4001, an HPV16 therapeutic vaccine, and avelumab (ave) in patients (pts) with immunotherapy-naïve recurrent and/or metastatic (R/M) HPV16-positive cervical or anogenital cancer.

2025 · Christophe Le Tourneau, Frederic Rolland, et al. · Journal of Clinical Oncology · 7

63MO TG4001 therapeutic vaccination combined with PD-L1 blocker avelumab remodels the tumor microenvironement (TME) and drives antitumor responses in human papillomavirus (HPV)+ malignancies

2020 · C. Le Tourneau, P. Cassier, et al. · Annals of Oncology · 5

793 TG4001 (Tipapkinogene sovacivec) and avelumab for recurrent/metastatic (R/M) human papilloma virus (HPV)-16+ cancers: clinical efficacy and immunogenicity

2020 · Christophe Le Tourneau, Philippe Cassier, et al. · 4

Immunogenicity and clinical activity of tipapkinogen sovacivec (TG4001), an HPV-16 cancer vaccine: A randomized phase 2 study in advanced anogenital cancers.

2023 · Christophe Le Tourneau, Frederic Rolland, et al. · Journal of Clinical Oncology · 1

955P Updated clinical results of BT-001, an oncolytic virus expressing an anti-CTLA4 mAb, administered in combination with pembrolizumab in patients with advanced solid tumors

2025 · C. Lebbe, R. Bahleda, et al. · Annals of Oncology

1592eP Pooled safety analysis of Modified Vaccinia virus Ankara-based therapeutic vaccine alone or in combination in cancer and cervical intraepithelial neoplasia (CIN) clinical trials

2025 · C.H.H. Ottensmeier, C. Le Tourneau, et al. · Annals of Oncology

Abstract CT045: A randomized phase II trial of TG4001 plus avelumab versus avelumab alone in recurrent/metastatic (R/M) human papilloma virus (HPV)-16 positive anogenital cancers

2023 · Christophe Le Tourneau, Frédéric Rolland, et al. · Cancer Research

Works count: 9

Citation count: 51

H-index: 4

I10-index: 2